UUS Practice Tests⌕ Search
Physician Board Certification

ABIM Advanced Heart Failure and Transplant Cardiology Initial Certification Examination Practice Test

Advanced heart failure and transplant cardiology centers on managing severe systolic dysfunction, evaluating candidacy for heart replacement, and selecting therapies when standard treatment is insufficient. Practice topics include hemodynamic assessment, pulmonary vascular resistance, mechanical circulatory support, inherited cardiomyopathy evaluation, and care of heart-transplant recipients.

Exam overview

Exam providerAmerican Board of Internal Medicine
Exam codeNot listed
CategoryPhysician Board Certification

About the ABIM Advanced Heart Failure and Transplant Cardiology Initial Cert… Exam

Clinical decisions in this field require interpreting cardiac output, filling pressures, and end-organ perfusion to determine when intravenous inotropes or temporary mechanical support may be appropriate. Transplant assessment includes evaluating pulmonary hypertension and reversibility, considering body size, and weighing comorbidities that affect candidacy. Long-term management also involves recognizing LVAD driveline infection, monitoring renal function and potassium after mineralocorticoid receptor antagonist initiation, and applying prognosis and goals of care when considering primary-prevention ICD therapy. Inherited cardiomyopathy cases call for identifying relatives who may benefit from family evaluation. Post-transplant care requires attention to immunosuppression and preventive care, including vaccination decisions. These scenarios test the ability to connect clinical findings with treatment choices and the risks of advanced therapies.

Sample Practice Questions

Review a selection from this exam's published US Practice Tests practice bank.

Question 1

A patient with advanced heart failure is being considered for heart transplantation and has a markedly elevated pulmonary vascular resistance. Why is reversibility testing clinically important?

  1. AIt estimates whether pulmonary vascular resistance can fall enough to reduce the risk of right-ventricular failure in the donor heart
  2. BIt determines whether the patient has coronary allograft vasculopathy
  3. CIt identifies whether the patient requires lifelong anticoagulation after transplantation
  4. DIt confirms the presence of acute cellular rejection
Show answerCorrect answer: A

Substantially elevated pulmonary vascular resistance can impose a dangerous afterload on the donor right ventricle. Hemodynamic testing with appropriate interventions helps assess whether the pulmonary vascular component is reversible and informs transplant risk and candidacy.

Question 2

A patient with a newly recognized dilated cardiomyopathy has a first-degree relative who died suddenly at a young age. The patient’s adult children ask whether they should be evaluated. Which approach is most appropriate?

  1. AOffer clinical screening and consider genetic counseling and testing based on the family and patient evaluation
  2. BRecommend evaluation only if the children develop heart-failure symptoms
  3. CAdvise that family assessment is unnecessary unless the patient has ischemic heart disease
  4. DTest the children with an indiscriminate panel and interpret any variant as causal
Show answerCorrect answer: A

Dilated cardiomyopathy can have a heritable basis, and a family history of premature sudden death increases concern. Clinical family screening and genetic counseling can guide appropriate testing and interpretation; a genetic result should be interpreted in clinical context.

Question 3

A patient with an LVAD presents with fever and erythema around the driveline exit site, with purulent drainage. Which action is most appropriate as part of the initial evaluation?

  1. AObtain cultures from the drainage and blood, and assess the extent of infection
  2. BRemove the LVAD immediately without further assessment
  3. CTreat with oral antifungal therapy without obtaining cultures
  4. DAssume the findings are sterile and observe without evaluation
Show answerCorrect answer: A

Suspected LVAD driveline infection warrants assessment for local and systemic involvement, including appropriate drainage and blood cultures, followed by treatment guided by severity and microbiology. Device removal is not an automatic initial step.

Question 4

A patient with advanced heart failure is being assessed for transplant candidacy and has severe obesity. Which principle best describes how body size should be considered in transplant evaluation?

  1. AAssess overall operative risk and candidacy; substantial obesity may warrant weight optimization before listing
  2. BBody mass index has no relevance to transplant outcomes or candidacy
  3. CObesity is an absolute contraindication in every transplant program and at any degree
  4. DA normal body mass index is required before any transplant evaluation can begin
Show answerCorrect answer: A

Obesity can increase perioperative and post-transplant risks, and substantial obesity may lead a program to recommend weight reduction before listing. Candidacy decisions are individualized and do not follow a universal absolute cutoff for every patient or program.

Question 5

A patient with advanced heart failure has a cardiac index of 1.7 L/min/m², elevated filling pressures, and worsening end-organ perfusion despite initial therapy. What is the principal role of a short-term intravenous inotrope in this setting?

  1. AImprove cardiac output and perfusion while the underlying strategy is reassessed
  2. BProvide permanent replacement for disease-modifying oral therapy
  3. CDirectly reverse myocardial fibrosis
  4. DPrevent all future ventricular arrhythmias
Show answerCorrect answer: A

Inotropes may be used short term in selected patients with low output and impaired perfusion to support cardiac output and end-organ function while clinicians address reversible causes and determine next steps, such as recovery, advanced therapies, or goals of care. They do not replace chronic disease-modifying therapy or reliably prevent arrhythmias.

Question 6

A patient with advanced heart failure is being considered for mechanical circulatory support. Which factor is most important when discussing the potential role of a temporary support device as a bridge to decision?

  1. AWhether temporary support can stabilize perfusion while candidacy and recovery potential are clarified
  2. BWhether the device guarantees eventual heart transplantation
  3. CWhether temporary support permanently eliminates the underlying cardiomyopathy
  4. DWhether the device can be selected without considering vascular access or bleeding risk
Show answerCorrect answer: A

Temporary mechanical circulatory support may stabilize a patient with severe hemodynamic compromise while clinicians assess reversibility, neurologic status, end-organ function, and eligibility for durable support or transplantation. It does not guarantee a particular long-term outcome and carries procedural risks.

Question 7

A heart-transplant recipient is receiving tacrolimus and mycophenolate. The recipient is due for routine seasonal influenza prevention. Which vaccination approach is generally appropriate?

  1. AUse an age-appropriate inactivated influenza vaccine
  2. BUse live-attenuated intranasal influenza vaccine
  3. CAvoid all influenza vaccination because immunosuppression makes it ineffective
  4. DGive a live-attenuated vaccine only during an episode of rejection
Show answerCorrect answer: A

Solid-organ transplant recipients are generally advised to receive an age-appropriate inactivated influenza vaccine. Live-attenuated vaccines are generally avoided in significantly immunosuppressed patients because of infection risk. Vaccination can still provide benefit despite a potentially reduced immune response.

How to use this practice test

Access is free. The question bank contains 50 published practice questions; each session presents up to 20 random questions. After completing a session, review the results to identify topics needing closer attention, such as transplant hemodynamics, device complications, or advanced heart failure treatment decisions.

Preparation tips

  • Practice calculating pulmonary vascular resistance from pulmonary artery pressure, wedge pressure, and cardiac output, then consider how reversibility testing informs transplant risk.
  • Compare indications and goals for short-term inotropes, temporary mechanical support, and durable LVAD therapy in patients with low output or worsening perfusion.
  • Review evaluation of LVAD driveline infection, including the initial assessment of local findings and systemic infection.
  • Connect HFrEF treatment decisions with safety monitoring, especially renal function and serum potassium after starting a mineralocorticoid receptor antagonist.
  • Review transplant follow-up considerations, including immunosuppression, seasonal influenza vaccination, and evaluation of relatives in suspected inherited cardiomyopathy.
Official sourceOfficial exam page ↗Official exam guide ↗